Clinical Trial Update: Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating haploidentical stem cell transplantation with prophylactic natural killer donor lymphocyte infusion in lymphoma, multiple myeloma, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Haploidentical hematopoietic stem cell transplantation (haploidentical hematopoietic stem cell transplantation)
• Natural killer donor lymphocyte infusion (donor lymphocyte infusion enriched for natural killer cells)

Snippet

Sponsor: Noah Merin | Conditions: Multiple Myeloma, CLL | Phase 1 | Status: COMPLETED